Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura
- 1 January 2004
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 41 (1), 4-14
- https://doi.org/10.1053/j.seminhematol.2003.10.003
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- Changes in von Willebrand factor–cleaving protease (ADAMTS13) activity after infusion of desmopressinBlood, 2003
- ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditionsBlood, 2002
- Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)Blood, 2002
- Processing of von Willebrand Factor by ADAMTS-13Biochemistry, 2002
- Von Willebrand factor–cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpuraBlood, 2002
- Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving proteaseBest Practice & Research Clinical Haematology, 2001
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelThe New England Journal of Medicine, 2000
- Abnormalities of von willebrand factor multimers in drug‐associated thrombotic microangiopathiesAmerican Journal of Hematology, 1993
- Unusually Large Plasma Factor VIII: von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic PurpuraThe New England Journal of Medicine, 1982
- Treatment of Thrombotic Thrombocytopenic Purpura with PlasmaThe New England Journal of Medicine, 1977